Neutralizing Antibodies and Antidrug Antibodies in the Ublituximab Phase 3 ULTIMATE I & II Studies in Relapsing Multiple Sclerosis

Drug Category : Array
Conference Category : Array
Lead Author : Alvarez E, et al.
Published Date : 24/02/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/02/ACTRIMS2022_Alvarez_ULTIMATE-I-and-II_2.24.22.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top